skip to main content

H.R. 2855: To deem the application submitted by Jaci Hermstad to the Food and Drug Administration for compassionate use of the gene therapy antisense oligonucleotides to be approved.


The text of the bill below is as of May 20, 2019 (Introduced).


V

116th CONGRESS

1st Session

H. R. 2855

IN THE HOUSE OF REPRESENTATIVES

May 20, 2019

introduced the following bill; which was referred to the Committee on Energy and Commerce

A BILL

To deem the application submitted by Jaci Hermstad to the Food and Drug Administration for compassionate use of the gene therapy antisense oligonucleotides to be approved.

1.

Deemed approval of application for compassionate use of the gene therapy antisense oligonucleotides

Notwithstanding the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 301 et seq.) or any other provision of law, the application submitted by Jaci Hermstad to the Food and Drug Administration for compassionate use of the gene therapy antisense oligonucleotides is deemed to be approved.